Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-<sc>l</sc>- Norleucine in Mice with Alphavirus Encephalomyel
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-<sc>l</sc>- Norleucine in Mice with Alphavirus Encephalomyel
10:6%3C1138::aid-cncr2820100608%3E3.0.co;2-k.fp.png "Pharmacological and initial therapeutic observations on 6‐Diazo‐5‐Oxo‐L‐ Norleucine (Don) in human neoplastic disease - Magill - 1957 - Cancer - Wiley Online Library")
Pharmacological and initial therapeutic observations on 6‐Diazo‐5‐Oxo‐L‐ Norleucine (Don) in human neoplastic disease - Magill - 1957 - Cancer - Wiley Online Library
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-Diazo-5-oxo-L-norleucine - Wikipedia
l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical
6-Diazo-5-oxo- L -norleucine crystalline 157-03-9
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
PDF) Discovery of 6-Diazo-5-oxo- l -norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment fo
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders | Journal of Medicinal Chemistry
CAS 157-03-9 6-DIAZO-5-OXO-L-NORLEUCINE products price,suppliers
